Download 2026/2027 Elite Nursing Exam Blueprint & Test Bank (88 Qs) and more Exams Nursing in PDF only on Docsity!
ELITE TEST BANK: CMDT
63RD ED. & 2026/
NURSING EXAM
BLUEPRINT
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook ○ The "Critical Action" Cheat Sheet ● PART II: THE ELITE TEST BANK ○ Section 1: Foundational Syntax & Application (Questions 1–28) Focus: 2026 AHA PREVENT, GOLD 'ABE', ADA AID Standards, MASLD Nomenclature, Texas SB 1188, KDIGO 2026. ○ Section 2: Professional Simulation (Questions 29–58) Focus: Acute Exacerbation Protocols, Sepsis Dynamic Resuscitation, JCAHO NPG 12, UT Austin Clinical Scenarios. ○ Section 3: Grandmaster Synthesis (Questions 59–88) Focus: Multi-System Failure, NRP 395L Quality Improvement, Automation Bias, Complex Delegation.
PART I: THE PRIMER
The "Welcome to the Big Leagues" Hook Welcome to the top tier of clinical practice. This test bank is engineered with a singular, ruthless purpose: to intercept high-stakes professional errors before they reach the bedside and to forge your academic knowledge into razor-sharp professional intuition. By mastering these 88 high-caliber scenarios, you are replacing outdated rote memorization with the dynamic, real-time clinical architecture required to lead in the 2026/2027 healthcare environment. The "Critical Action" Cheat Sheet Clinical Domain Legacy Standard (Obsolete)
2026/2027 Redline Standard (Current)
Clinical Rationale
AHA Dyslipidemia Pooled Cohort Equations (10-yr risk).
PREVENT-CVD
Calculator (10- & 30-yr risk).
Eliminates race; integrates Social Deprivation Index (SDI) and kidney metrics (UACR). Early statin initiation for high 30-yr
Clinical Domain Legacy Standard (Obsolete)
2026/2027 Redline Standard (Current)
Clinical Rationale
risk. GOLD COPD Group A, B, C, D; step-up after 2 failures.
Group A, B, E Classification.
A single moderate exacerbation mandates Group E classification and immediate escalation to dual LABA/LAMA therapy to prevent 30-day MACE. Sepsis Resuscitation Mandatory 30 mL/kg fluid bolus.
Dynamic Fluid Assessment.
Static boluses cause ARDS. Use pulse pressure variation (PPV) or passive leg raise (PLR) to guide fluids. Escalate to pressors early. ADA Diabetes Tech Step-therapy; C-peptide prerequisites.
Automated Insulin Delivery (AID).
AID is the absolute preferred standard for all T1D and insulin-dependent T2D at diagnosis. Removes access barriers. JCAHO Staffing Headcount/Financial staffing matrices.
NPG 12 Acuity-Based Staffing.
The Nurse Executive is federally mandated to match staff competencies directly to patient acuity. Ensures 24/7 RN oversight. Texas SB 1188 Unregulated Ambient AI use.
Mandatory Patient Disclosure.
Practitioners using AI for documentation/diagnos tics must disclose its use and hold total liability for hallucinated data.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application
Q1: According to the 2026 AHA Dyslipidemia Guidelines, which novel risk assessment tool is the FIRST choice for evaluating a 35-year-old patient for primary prevention of atherosclerotic cardiovascular disease (ASCVD)? A) The Pooled Cohort Equations (PCE) to estimate 10-year risk. B) The PREVENT-CVD calculator to estimate 10-year and 30-year risk. C) The Framingham Risk Score targeting solely LDL cholesterol. D) The AHA/ACC 2018 ASCVD Risk
bronchodilation instantly to prevent the next, potentially fatal, decompensation. Q4: In 2026, the nomenclature for non-alcoholic fatty liver disease (NAFLD) was officially changed. Which term is MOST APPROPRIATE for a nurse practitioner to use in clinical documentation for a patient with hepatic steatosis driven by metabolic syndrome? A) Non-alcoholic steatohepatitis (NASH). B) Metabolic dysfunction-associated steatotic liver disease (MASLD). C) Cryptogenic steatotic liver disease. D) Benign hepatic steatosis. ● The Answer: B (Metabolic dysfunction-associated steatotic liver disease (MASLD).) ● Distractor Analysis: ○ A is incorrect: NASH is stigmatizing and clinically inaccurate; it has been replaced by MASH. ○ C is incorrect: Cryptogenic is reserved only for patients with no identifiable metabolic or alcohol-related cause. ○ D is incorrect: Steatosis driven by metabolic syndrome is never "benign" and requires aggressive cardiometabolic intervention. The Mentor's Analysis: Words dictate clinical pathways. The shift to MASLD removes the stigma of "alcoholic" terminology while correctly identifying the true enemy: metabolic dysfunction. Professional Intuition: When you document MASLD, you instantly trigger the systemic cardiometabolic workflow (GLP-1s, statins, PREVENT-CVD). Q5: The 2026 American College of Gastroenterology (ACG) guidelines dictate a fundamental shift in the primary treatment of Helicobacter pylori. Which regimen is the FIRST-LINE standard for a treatment-naïve patient with unknown antibiotic susceptibility? A) 7-day standard PPI-clarithromycin triple therapy. B) 14-day optimized Bismuth Quadruple Therapy (BQT). C) 10-day sequential therapy utilizing levofloxacin. D) 14-day high-dose amoxicillin monotherapy. ● The Answer: B (14-day optimized Bismuth Quadruple Therapy (BQT).) ● Distractor Analysis: ○ A is incorrect: PPI-clarithromycin triple therapy is expressly forbidden unless susceptibility testing confirms clarithromycin sensitivity, due to massive resistance rates. ○ C is incorrect: Levofloxacin should only be used if confirmed by antimicrobial susceptibility testing. ○ D is incorrect: Amoxicillin is used in dual therapy with vonoprazan, never as monotherapy for H. pylori. The Mentor's Analysis: Macrolide resistance has broken the old algorithms. Using empiric clarithromycin in 2026 is clinical negligence. Bismuth quadruple therapy bypasses standard resistance mechanisms. Professional Intuition: Never guess with antibiotics in GI eradication. If you lack resistance data, hit it with optimized BQT or Vonoprazan dual therapy. Q6: Under the Texas SB 1188 (2025/2026) mandate regarding "Ambient AI" in the clinical setting, what is the IMMEDIATE legal responsibility of the practitioner utilizing an AI scribe for diagnostic assistance? A) Upload the patient's data to a decentralized blockchain for anonymity. B) Provide explicit, plain-language disclosure to the patient that AI is being used. C) Have a secondary physician co-sign the AI-generated note within 72 hours. D) Use "dark patterns" in the consent form to secure rapid data usage rights. ● The Answer: B (Provide explicit, plain-language disclosure to the patient that AI is being used.) ● Distractor Analysis: ○ A is incorrect: Blockchain is not a legal mandate under SB 1188. ○ C is incorrect: The practitioner using the AI must review and take ownership of the note; a secondary physician is not mandated.
○ D is incorrect: The law explicitly forbids using deceptive "dark patterns" to obscure AI disclosure. The Mentor's Analysis: AI is a tool, not a shield. When you use Ambient AI to document, you assume total legal liability for its output. Texas SB 1188 mandates transparency so the patient understands how their data is processed. Professional Intuition: Disclosure builds trust; rigorous manual review of AI output prevents automation bias. Q7: A patient with chronic kidney disease (CKD) Stage G4 presents with anemia. Following the KDIGO 2026 Anemia Guidelines, the practitioner notes a ferritin level of 850 ng/mL and a TSAT of 45%. What is the MOST APPROPRIATE action regarding intravenous (IV) iron therapy? A) Administer IV iron aggressively to prevent the need for an ESA. B) Withhold IV iron therapy. C) Switch to oral iron supplementation to bypass hepatic block. D) Administer a red blood cell (RBC) transfusion immediately. ● The Answer: B (Withhold IV iron therapy.) ● Distractor Analysis: ○ A is incorrect: Pushing iron into a saturated system causes severe oxidative stress and iron toxicity. ○ C is incorrect: Oral iron will not be absorbed due to high hepcidin levels in advanced CKD and high ferritin states. ○ D is incorrect: KDIGO 2026 emphasizes minimizing transfusions to protect transplant eligibility; there is no indication of critical instability here. The Mentor's Analysis: The 2026 KDIGO guidelines establish a hard ceiling: withhold iron when ferritin exceeds 700 ng/mL or TSAT is ≥40%. In CKD, high ferritin often reflects inflammation, not just iron stores. Professional Intuition: More iron is not always the answer for anemia. Respect the saturation thresholds to prevent iatrogenic organ damage. Q8: Which novel pharmacological agent, newly highlighted in 2026/2027 clinical standards, is a highly selective NaV1.8 inhibitor utilized for acute pain management to entirely bypass the mu-opioid receptor? A) Crinecerfont B) Suzetrigine C) Bempedoic acid D) Vonoprazan ● The Answer: B (Suzetrigine) ● Distractor Analysis: ○ A is incorrect: Crinecerfont is utilized for congenital adrenal hyperplasia, not acute pain. ○ C is incorrect: Bempedoic acid is an ATP citrate lyase inhibitor for dyslipidemia. ○ D is incorrect: Vonoprazan is a potassium-competitive acid blocker (PCAB) for H. pylori and GERD. The Mentor's Analysis: The opioid epidemic forced a pharmacological evolution. Suzetrigine acts on the peripheral nervous system (NaV1.8) to block pain signal propagation without engaging the central nervous system's addiction pathways. Professional Intuition: When treating acute pain in high-risk demographics, prioritize peripheral blockade over central nervous system depression. Q9: According to the "T.A.P.E. Doctrine" utilized in UT Austin's clinical delegation frameworks, which task can a Registered Nurse (RN) legally delegate to a Licensed Practical Nurse (LPN/LVN)? A) The initial teaching of a newly diagnosed diabetic on AID system management. B) The formulation of the primary nursing care plan for a post-operative patient. C) The administration of routine oral antihypertensive medications to a stable patient. D) The evaluation of a patient's response to an initial dose of a high-risk IV antibiotic. ● The Answer: C (The administration of routine oral antihypertensive medications to a stable patient.) ● Distractor Analysis:
165 mg/dL. What is the MOST APPROPRIATE intervention? A) Advise lifestyle modifications and reassess in 10 years when age-related risk increases. B) Initiate a moderate-to-high intensity statin therapy immediately. C) Order a coronary artery bypass graft (CABG) evaluation. D) Start a PCSK9 inhibitor as first-line monotherapy. ● The Answer: B (Initiate a moderate-to-high intensity statin therapy immediately.) ● Distractor Analysis: ○ A is incorrect: "Watchful waiting" until age 55 allows decades of atherogenic plaque accumulation. ○ C is incorrect: CABG is for severe, obstructive clinical ASCVD, not primary prevention. ○ D is incorrect: Statins remain the bedrock of primary prevention; PCSK9 inhibitors are an escalation, not a first-line starting point. The Mentor's Analysis: The AHA 2026 guidelines demolished the idea that young age equals low risk. High LDL is a cumulative toxin. By initiating a statin at age 45 based on 30-year risk, you are actively preventing the myocardial infarction they were destined to have at 65. Professional Intuition: Cholesterol is a "time-under-tension" variable. Treat the 30-year risk to erase the 10-year event. Q13: According to the 2026 Surviving Sepsis Campaign guidelines, which method is STRONGLY PREFERRED for guiding intravenous fluid resuscitation in a patient with septic shock? A) Administering a mandatory 30 mL/kg bolus based on ideal body weight. B) Utilizing dynamic measures such as pulse pressure variation or passive leg raise. C) Targeting a Central Venous Pressure (CVP) of 8-12 mmHg. D) Strictly monitoring hourly urine output via a Foley catheter as the primary indicator. ● The Answer: B (Utilizing dynamic measures such as pulse pressure variation or passive leg raise.) ● Distractor Analysis: ○ A is incorrect: The rigid 30 mL/kg rule was downgraded to a weak recommendation; fluid overload kills septic patients. ○ C is incorrect: CVP is a static measure and a historically poor predictor of fluid responsiveness. ○ D is incorrect: Urine output is a lagging indicator of perfusion, not a dynamic measure of fluid responsiveness. The Mentor's Analysis: Pumping 3 liters of fluid into a patient who is already vasoplegic and "full" destroys the endothelial glycocalyx and causes ARDS. Dynamic measures ask the body a question: "If I give you fluid, will your cardiac output increase?" Professional Intuition: Never guess with fluids in 2026. If the tank is full, reach for norepinephrine, not more normal saline. Q14: In the UT Austin School of Nursing DNP blueprint, adhering to ISO 80369-3 standards, what is the MANDATORY physical connector type used for all enteral feeding tubes to prevent catastrophic misconnections? A) Luer-lock syringes. B) ENFit connectors. C) Standard slip-tip syringes. D) Neuraxial specific epidural connectors. ● The Answer: B (ENFit connectors.) ● Distractor Analysis: ○ A is incorrect: Luer-locks are utilized for IV access. Connecting enteral feed to an IV Luer-lock is a fatal never-event. ○ C is incorrect: Slip-tips are easily confused and lack the engineering controls to prevent misconnections. ○ D is incorrect: Neuraxial connectors (NRFit) are exclusively for spinal/epidural lines. The Mentor's Analysis: Human error is inevitable under stress; engineering controls are not.
ENFit connectors are physically designed (female administration to male patient access) so that it is mathematically impossible to connect a tube feeding syringe to a central venous catheter. Professional Intuition: System design always beats human vigilance. Rely on the physical hard-stop. Q15: A patient with MASLD and Type 2 Diabetes requires glycemic optimization. Under the 2026 ADA Standards of Care, which pharmacologic class is PREFERRED due to its demonstrated benefit on both glycemic control and metabolic steatohepatitis (MASH)? A) Sulfonylureas (e.g., Glipizide) B) Thiazolidinediones (e.g., Pioglitazone) C) GLP-1 Receptor Agonists (e.g., Semaglutide) D) Dipeptidyl peptidase 4 (DPP-4) inhibitors (e.g., Sitagliptin) ● The Answer: C (GLP-1 Receptor Agonists (e.g., Semaglutide)) ● Distractor Analysis: ○ A is incorrect: Sulfonylureas cause weight gain and hypoglycemia, worsening the metabolic profile. ○ B is incorrect: While Pioglitazone has some legacy use in liver disease, GLP-1s and dual GIP/GLP-1 RAs are the explicit 2026 preferred standard for MASLD/MASH. ○ D is incorrect: DPP-4 inhibitors are weight-neutral and lack the potent cardiometabolic and hepatic benefits of GLP-1s. The Mentor's Analysis: We no longer treat "blood sugar" in a vacuum. MASLD, obesity, and Type 2 Diabetes are the exact same metabolic infrastructure collapsing from different angles. GLP-1 RAs treat the root cause—metabolic dysfunction—while stripping fat from the liver. Professional Intuition: Always select the drug that hits multiple organ systems simultaneously. One molecule, three therapeutic targets. Q16: When performing a 2026 Video Performance Exam (VPE) under strict academic integrity protocols (UT Austin N224), what action by the student will result in an IMMEDIATE score of zero? A) Pausing to mentally recall the exact steps of a cranial nerve assessment. B) Receiving off-camera verbal coaching or instruction from the videographer. C) Correcting a minor sterile field break immediately and verbalizing the correction. D) Utilizing a standardized patient who is a peer rather than a mannequin. ● The Answer: B (Receiving off-camera verbal coaching or instruction from the videographer.) ● Distractor Analysis: ○ A is incorrect: Pausing to think demonstrates cognitive processing, not cheating. ○ C is incorrect: Recognizing and instantly mitigating a sterile break is the hallmark of professional clinical judgment. ○ D is incorrect: Standardized peer patients are often required for VPEs. The Mentor's Analysis: A performance exam evaluates your autonomous clinical architecture. If someone else provides the data, the integrity of the assessment is destroyed. In the real world, you cannot look off-camera for the answer when a patient codes. Professional Intuition: Own your knowledge. Competence is forged in isolation, not through whispered hints. Q17: A 68-year-old patient with severe COPD is admitted for an exacerbation. They are persistently hypoxemic but cannot tolerate noninvasive mechanical ventilation (NIV) due to claustrophobia. According to the 2026 GOLD report, what is the FIRST-LINE alternative respiratory support? A) Immediate endotracheal intubation and invasive mechanical ventilation. B) High Flow Nasal Therapy (HFNT). C) Simple nasal cannula at 6 L/min. D) Subcutaneous epinephrine to force bronchodilation. ● The Answer: B (High Flow Nasal Therapy (HFNT).) ● Distractor Analysis: ○ A is incorrect: Intubating a COPD patient is a last resort due to the extreme difficulty
blood gas (ABG) reveals a pH of 7.28 and a PaCO2 of 62 mmHg. Based on the 2026 GOLD classification, this presentation defines which specific severity of COPD exacerbation? A) Mild Exacerbation. B) Moderate Exacerbation. C) Severe Exacerbation (with Hypercapnic Acidosis). D) Chronic compensated respiratory failure. ● The Answer: C (Severe Exacerbation (with Hypercapnic Acidosis).) ● Distractor Analysis: ○ A is incorrect: Mild is treated with short-acting bronchodilators only; no acidosis is present. ○ B is incorrect: Moderate involves antibiotics/corticosteroids but lacks acute acidosis. ○ D is incorrect: Compensated failure would show a normal pH (e.g., 7.36) with elevated bicarbonate, not an acute acidotic drop to 7.28. The Mentor's Analysis: The 2026 GOLD criteria drew a hard line in the sand: a pH < 7.35 with a PaCO2 > 45 mmHg is the definitive biochemical marker of a severe, life-threatening exacerbation. This patient's ventilatory drive has failed. Professional Intuition: When the pH drops, the patient buys a ticket to the ICU. Prepare for immediate BiPAP or intubation. Q21: You are reviewing a research article for a DNP quality improvement project (NRP 395L). The study evaluates the "lived experiences of nurse practitioners during a strike." According to Polit & Beck’s 12th Edition, what qualitative methodology is being utilized? A) Randomized Controlled Trial (RCT) B) Phenomenological Hermeneutics C) Multivariate Regression Analysis D) Retrospective Cohort Synthesis ● The Answer: B (Phenomenological Hermeneutics) ● Distractor Analysis: ○ A is incorrect: An RCT is a quantitative, experimental design, not qualitative. ○ C is incorrect: Multivariate regression is a complex statistical formula used in quantitative data. ○ D is incorrect: A cohort study tracks clinical outcomes over time (quantitative epidemiology). The Mentor's Analysis: "Lived experience" is the ultimate buzzword for Phenomenology. Hermeneutics adds the layer of interpreting that experience. In DNP practice, you must be able to translate abstract academic methodologies into real-world evidence appraisals. Professional Intuition: Numbers tell you if a protocol works (Quantitative). Human stories tell you why the staff refuses to use it (Qualitative). Q22: When utilizing the ADA 2026 Standards for a patient with Type 2 Diabetes attempting to lose weight, what is the MINIMUM targeted weight loss percentage clinically proven to improve hyperglycemia and cardiometabolic risk? A) 1% to 2% B) 5% to 7% C) 15% to 20% D) 25% or greater ● The Answer: B (5% to 7%) ● Distractor Analysis: ○ A is incorrect: 1-2% is insufficient to reverse hepatic steatosis or insulin resistance. ○ C is incorrect: While 15% yields massive benefits, it is not the minimum threshold required to see clinical baseline improvement. ○ D is incorrect: 25% is an extreme target that may cause lean muscle mass wasting if not managed carefully. The Mentor's Analysis: Patients are easily demoralized by massive weight loss goals. The 2026 ADA data proves that just a 5% to 7% reduction in total body weight initiates a cascade of metabolic healing, improving insulin sensitivity and lowering ASCVD risk. Professional Intuition: Give patients achievable milestones. Five percent is the metabolic tipping point. Q23: A nurse practitioner is treating a 45-year-old with H. pylori. The patient has a documented,
severe anaphylactic allergy to Penicillin. Under the 2026 ACG guidelines, which empiric regimen is the SAFEST and most effective alternative to Bismuth Quadruple Therapy? A) Amoxicillin high-dose dual therapy. B) Rifabutin triple therapy or Vonoprazan dual therapy (without amoxicillin). C) PPI-Clarithromycin-Amoxicillin triple therapy. D) Cephalexin-based sequential therapy. ● The Answer: B (Rifabutin triple therapy or Vonoprazan dual therapy (without amoxicillin).) ● Distractor Analysis: ○ A is incorrect: Amoxicillin is a penicillin derivative; this will trigger anaphylaxis. ○ C is incorrect: Contains amoxicillin; additionally, empiric clarithromycin is contraindicated. ○ D is incorrect: Cephalosporins have cross-reactivity with penicillins and are not standard H. pylori eradication agents. The Mentor's Analysis: The ACG updated the algorithms specifically to handle the dual threat of macrolide resistance and penicillin allergies. Rifabutin bypasses the allergy and the resistance. Professional Intuition: Never compromise an airway to cure an ulcer. Always verify cross-reactivity before prescribing. Q24: In the context of Joint Commission NPG 12, what specifically must the Nurse Executive validate to legally ensure safe, acuity-based staffing? A) That the hospital meets the minimum financial budget for the fiscal quarter. B) That all physicians are trained on the latest Ambient AI documentation software. C) That staffing decisions are grounded in the verified clinical competencies of the staff matched to the complexity of the patients. D) That the hospital achieves a 0% rate of central line-associated bloodstream infections (CLABSI). ● The Answer: C (That staffing decisions are grounded in the verified clinical competencies of the staff matched to the complexity of the patients.) ● Distractor Analysis: ○ A is incorrect: NPG 12 explicitly divorces staffing minimums from purely financial/administrative constraints. ○ B is incorrect: AI documentation is an IT/compliance issue, not the core metric of NPG 12 staffing. ○ D is incorrect: While zero CLABSI is a quality goal, it is an outcome metric, not the structural staffing mandate required by NPG 12. The Mentor's Analysis: NPG 12 is the ultimate weapon against dangerous assignments. It legally requires the Nurse Executive to prove that the nurse assigned to the complex patient actually has the specialized training to keep them alive. Professional Intuition: A warm body is not a competent clinician. Staffing without competency validation is institutional negligence. Q25: A patient with advanced NSCLC receives a biomarker report indicating an EGFR exon 19 deletion. Prior to initiating systemic therapy, the 2026 NCCN guidelines classify which of the following as a CATEGORY 1 PREFERRED frontline regimen? A) Carboplatin and Paclitaxel alone. B) Amivantamab-vmjw plus Lazertinib. C) Nivolumab monotherapy. D) Standard hospice palliation. ● The Answer: B (Amivantamab-vmjw plus Lazertinib.) ● Distractor Analysis: ○ A is incorrect: Blunt chemotherapy is obsolete as a frontline monotherapy for genetically mutated NSCLC. ○ C is incorrect: Immunotherapy lacks efficacy against EGFR-driven tumors in the frontline setting. ○ D is incorrect: With targeted therapies, advanced NSCLC can be managed chronologically for years; immediate hospice is premature.
zero exacerbations.) ● Distractor Analysis: ○ A is incorrect: One moderate exacerbation disqualifies him from the low-risk Group A. ○ C is incorrect: Group B is for high symptoms but zero exacerbations. ○ D is incorrect: Group C is obsolete in the 2026 ABE classification. The Mentor's Analysis: The "E" stands for Exacerbation. The 2026 guidelines shifted the paradigm: one moderate strike moves you to the high-risk category. Our goal is no longer just "managing" exacerbations; it is completely extinguishing disease activity. Professional Intuition: Exacerbations destroy lung parenchyma irreversibly. Zero is the only acceptable number.
Section 2: Professional Simulation
Q29: You are an ICU nurse managing a 58-year-old patient in septic shock. The patient's MAP is 54 mmHg despite receiving 1 liter of lactated Ringer's. Their lactate is 4.8 mmol/L. The legacy order set suggests giving another 2 liters of fluid to meet the 30 mL/kg quota. You perform a passive leg raise (PLR), and the patient's pulse pressure does not increase. What is your IMMEDIATE action? A) Administer the remaining 2 liters of fluid to comply with the 30 mL/kg core measure. B) Escalate immediately to a peripheral norepinephrine infusion and hold further fluids. C) Administer IV furosemide to diurese the unresponsive fluid. D) Order a stat red blood cell transfusion to increase oxygen delivery. ● The Answer: B (Escalate immediately to a peripheral norepinephrine infusion and hold further fluids.) ● Distractor Analysis: ○ A is incorrect: A negative PLR means the heart is on the flat portion of the Starling curve; more fluid will cause pulmonary edema, not increase blood pressure. The 2026 guideline makes 30 mL/kg a weak, conditional rule. ○ C is incorrect: Diuresing a hypotensive, septic patient will crash their preload and cause immediate cardiac arrest. ○ D is incorrect: Blood is indicated for Hb < 7.0 g/dL, not for primary vasoplegic shock. The Mentor's Analysis: This is the exact scenario where 2026 protocols save lives. The tank is full, but the pipes are dilated. Pumping more fluid into dilated pipes floods the lungs. The negative PLR proves fluid unresponsiveness. Professional Intuition: When fluid fails to stretch the ventricle, squeeze the vessels. Initiate early norepinephrine. Q30: A provider utilizes an Ambient AI application on their smartphone to listen to a patient encounter and generate a SOAP note. Following Texas SB 1188 protocols, the provider informs the patient. What is the NEXT required step before signing the note into the electronic health record (EHR)? A) The provider must rigorously review the AI-generated text to ensure it meets Texas Medical Board standards, accepting total liability for its accuracy. B) The provider must blindly sign the note to maximize workflow efficiency and billable hours. C) The provider must run the note through a secondary AI plagiarism checker. D) The provider must delete the ambient audio file in front of the patient. ● The Answer: A (The provider must rigorously review the AI-generated text to ensure it meets Texas Medical Board standards, accepting total liability for its accuracy.) ● Distractor Analysis: ○ B is incorrect: Blindly signing AI output is a direct violation of clinical standards and
is known as "automation bias". ○ C is incorrect: Plagiarism is an academic concept, irrelevant to clinical documentation accuracy. ○ D is incorrect: Audio file retention is governed by HIPAA/vendor contracts, not an immediate bedside requirement under SB 1188. The Mentor's Analysis: AI hallucination in a medical record is a ticking legal time bomb. SB 1188 explicitly demands that the clinician acts as the final firewall. If the AI hallucinates a penicillin allergy and you sign it, you committed the malpractice. Professional Intuition: Trust, but rigorously verify. You cannot outsource your clinical license to an algorithm. Q31: A 42-year-old patient with MASLD, obesity, and an HbA1c of 8.2% is evaluated in the clinic. The practitioner decides to initiate a GLP-1 Receptor Agonist. The patient asks, "Why this drug instead of the cheap pill my father took?" What is the MOST ACCURATE evidence-based response based on 2026 standards? A) "This medication forces your pancreas to release insulin continuously, regardless of what you eat." B) "This medication targets the root metabolic dysfunction, helping you lose weight, lowering your blood sugar, and actively reducing the fat buildup in your liver." C) "This medication is required by insurance before we can prescribe the older, cheaper pills." D) "This medication acts as a diuretic to excrete excess sugar and water through your urine." ● The Answer: B ("This medication targets the root metabolic dysfunction, helping you lose weight, lowering your blood sugar, and actively reducing the fat buildup in your liver.") ● Distractor Analysis: ○ A is incorrect: Describes sulfonylureas, not GLP-1s. GLP-1s are glucose-dependent. ○ C is incorrect: GLP-1s are a preferred first-line agent for this specific metabolic profile; step-therapy is an outdated barrier. ○ D is incorrect: Describes SGLT-2 inhibitors, not GLP-1s. The Mentor's Analysis: Patient buy-in is directly proportional to their understanding of the mechanism of action. When you explain that MASH, diabetes, and obesity are interconnected, the patient understands why a systemic drug like a GLP-1 is superior to an isolated glucose-lowering pill. Professional Intuition: Educate patients on the 'Why.' Compliance skyrockets when they realize the drug is healing their liver, not just tweaking a lab value. Q32: You are the charge nurse during a night shift. A provider orders an aggressive IV iron infusion for a CKD G5 patient with a ferritin of 800 ng/mL. Based on KDIGO 2026 guidelines, what is your FIRST action? A) Delegate the administration to a newly graduated RN to provide them with clinical experience. B) Hang the IV iron but run it at half the prescribed rate to minimize toxicity. C) Utilize the chain of command to challenge the order, citing the KDIGO threshold of 700 ng/mL. D) Administer prophylactic diphenhydramine to prevent an anaphylactic reaction to the iron. ● The Answer: C (Utilize the chain of command to challenge the order, citing the KDIGO threshold of 700 ng/mL.) ● Distractor Analysis: ○ A is incorrect: Delegating a dangerous, contraindicated order is a failure of leadership. ○ B is incorrect: Running a contraindicated drug slower does not negate the contraindication. ○ D is incorrect: While premedication is sometimes used for iron, it does not fix the underlying physiological contraindication of iron overload. The Mentor's Analysis: The 2026 KDIGO guideline provides a hard, empirical redline: 700
authority to deploy surge-staffing or float-pool RNs, documenting the acuity-based rationale. D) Instruct the RNs to skip documentation to save time. ● The Answer: C (Exercise executive authority to deploy surge-staffing or float-pool RNs, documenting the acuity-based rationale.) ● Distractor Analysis: ○ A is incorrect: NPG 12 explicitly overrides financial matrices if patient safety is compromised. ○ B is incorrect: UAPs cannot assess, evaluate, or monitor unstable post-operative patients (T.A.P.E. Doctrine). ○ D is incorrect: Skipping documentation is illegal and destroys the medical record. The Mentor's Analysis: NPG 12 is not a suggestion; it is a Joint Commission mandate. The Nurse Executive is the ultimate clinical authority regarding staffing. If the acuity demands more nurses, the matrix must yield. Professional Intuition: Defend the license of your floor nurses by providing the resources they need. Safe staffing is the foundation of all clinical outcomes. Q36: A patient with H. pylori is prescribed 14-day optimized Bismuth Quadruple Therapy. During discharge teaching, the patient asks what side effects are normal. What must the nurse EXPLICITLY teach to prevent unnecessary panic and ER visits? A) "You may experience temporary blindness, but it will resolve." B) "Your stool will likely turn pitch black, and your tongue may darken; this is a harmless effect of the bismuth." C) "You will likely develop a severe, raised, red rash across your chest." D) "Your heart rate will drop into the 30s." ● The Answer: B ("Your stool will likely turn pitch black, and your tongue may darken; this is a harmless effect of the bismuth.") ● Distractor Analysis: ○ A is incorrect: Blindness is a severe, never-normal adverse event. ○ C is incorrect: A severe rash indicates a potential Stevens-Johnson syndrome or anaphylaxis to the antibiotics. ○ D is incorrect: Severe bradycardia is not a standard side effect of BQT. The Mentor's Analysis: Anticipatory guidance prevents system overload. Patients taking bismuth who are not warned about melena-like dark stools will panic, assuming they have an upper GI bleed, and rush to the emergency department. Professional Intuition: Preempt the panic. Tell the patient exactly what weird, harmless things the drug will do to their body. Q37: You are evaluating a patient utilizing an Automated Insulin Delivery (AID) system. The patient's Time-in-Range (TIR) is 85%, and their HbA1c is 6.4%. They report zero episodes of severe hypoglycemia. According to 2026 ADA guidelines, what is the NEXT step? A) Discontinue the AID system as the patient is now "cured." B) Praise the patient, maintain the current AID system, and assess the psychosocial impact of device use. C) Increase the basal rate to drive the HbA1c below 5.0%. D) Switch the patient to sliding scale insulin to test their pancreatic reserve. ● The Answer: B (Praise the patient, maintain the current AID system, and assess the psychosocial impact of device use.) ● Distractor Analysis: ○ A is incorrect: T1D/insulin-dependent T2D is a chronic condition; removing the tech guarantees immediate relapse. ○ C is incorrect: An A1c of < 7.0% with high TIR is the ideal target. Pushing to 5.0% risks fatal hypoglycemia. ○ D is incorrect: Sliding scale is an obsolete, reactive therapy. The Mentor's Analysis: A TIR of >70% is clinical excellence. The technology is working flawlessly. However, device fatigue is real. The ADA 2026 guidelines emphasize screening for
the psychosocial burden of living tethered to a machine. Professional Intuition: Treat the human attached to the pump. Validate their effort and monitor for burnout. Q38: A patient presents to the ER with severe, crushing leg pain following a motor vehicle collision. The patient has a documented history of severe opioid use disorder (OUD) and is currently on buprenorphine. The provider prescribes Suzetrigine. What is the PHYSIOLOGICAL RATIONALE for this choice? A) Suzetrigine acts as a competitive antagonist at the mu-opioid receptor, precipitating withdrawal. B) Suzetrigine is a potent NSAID that strictly reduces localized inflammation. C) Suzetrigine blocks peripheral NaV1.8 sodium channels, halting pain signals without interacting with central opioid receptors. D) Suzetrigine is a synthetic opioid that overrides the buprenorphine blockade. ● The Answer: C (Suzetrigine blocks peripheral NaV1.8 sodium channels, halting pain signals without interacting with central opioid receptors.) ● Distractor Analysis: ○ A is incorrect: Naloxone/Naltrexone are antagonists. Suzetrigine does not touch the opioid receptors. ○ B is incorrect: It is not an NSAID; it is a selective voltage-gated sodium channel inhibitor. ○ D is incorrect: It is explicitly a non-opioid medication. The Mentor's Analysis: Treating acute pain in a patient recovering from OUD is a historical nightmare. You either leave them in agony or risk a fatal relapse. Suzetrigine is the 2026/ silver bullet: it shuts down the peripheral pain wire (NaV1.8) without ever knocking on the door of the brain's addiction centers. Professional Intuition: Understand the receptor. Bypass the CNS to treat the pain without triggering the addiction. Q39: You are performing a mandatory UT Austin DNP Video Performance Exam (VPE). You complete a flawless cardiovascular assessment but realize you forgot to clean your stethoscope prior to touching the patient. The camera is still rolling. What is the ONLY acceptable action according to strict academic rubric standards? A) Stop the recording, delete the file, and request a formal retest, as infection control is a hard failure. B) Verbalize the mistake, clean the stethoscope on camera, and continue, demonstrating real-time clinical correction. C) Edit the video to splice in a clip of you cleaning it. D) Whisper to the patient to say the stethoscope was clean. ● The Answer: B (Verbalize the mistake, clean the stethoscope on camera, and continue, demonstrating real-time clinical correction.) ● Distractor Analysis: ○ A is incorrect: While it's a deduction, a safe practitioner catches their error and fixes it. ○ C is incorrect: Splicing/editing a VPE violates the Honor Code (Zero tolerance). ○ D is incorrect: Collusion with the patient violates the Honor Code. The Mentor's Analysis: Clinical practice is not about being flawless; it is about absolute integrity. If you break an infection control protocol, you own it, you verbalize it, and you fix it in real-time. Cover-ups kill patients; transparency saves them. Professional Intuition: Your integrity is your license. Never edit the truth. Q40: A patient is recovering from a severe COPD exacerbation. They are ready for discharge. According to the 2026 GOLD report, what is a MANDATORY secondary prevention screening that must be addressed prior to or shortly after discharge due to their heightened 30-day risk profile? A) Screening for prostate cancer. B) Evaluation for major adverse cardiovascular events (MACE), as the risk doubles following a moderate/severe exacerbation. C) A full colonoscopy to rule out ischemic colitis. D) A lumbar puncture to rule out meningitis.
H. pylori. Old PPIs were slow and erratic. Vonoprazan (a PCAB) acts like a light switch, instantly shutting down acid production to create the perfect environment for the antibiotic to execute the bacteria. Professional Intuition: Control the pH, and you control the infection. Q43: You are reviewing a patient’s lipid panel. They have an LDL of 195 mg/dL and are diagnosed with heterozygous familial hypercholesterolemia (HeFH). According to the 2026 ACC/AHA Dyslipidemia guidelines, what is the absolute LDL-C goal for this specific patient? A) < 130 mg/dL B) < 100 mg/dL C) < 70 mg/dL D) < 55 mg/dL ● The Answer: C (< 70 mg/dL) ● Distractor Analysis: ○ A is incorrect: 130 is completely obsolete. ○ B is incorrect: For LDL > 190, the goal is < 100 unless they have HeFH or another risk factor, which drops the target lower. ○ D is incorrect: < 55 mg/dL is for secondary prevention (clinical ASCVD), not primary genetic hypercholesterolemia. The Mentor's Analysis: The 2026 guidelines removed the ambiguity. If the patient has HeFH, their vessels have been bathed in toxic levels of LDL since birth. You must aggressively drive the LDL below 70 mg/dL to halt the accelerated atherosclerotic process. Professional Intuition: Genetics load the gun. Statins, ezetimibe, and PCSK9 inhibitors empty the chamber. Q44: A patient is on continuous enteral tube feeding via a nasogastric tube. The nurse needs to administer crushed medications. Under ISO 80369-3, the nurse must use an ENFit syringe. What happens if the nurse attempts to connect a standard IV Luer-lock syringe to the patient's feeding tube port? A) The syringe will connect loosely, risking a medication leak. B) The connection is mathematically and physically impossible, preventing a wrong-route error. C) The syringe will connect securely, but an alarm will sound on the feeding pump. D) The syringe will shatter under the pressure. ● The Answer: B (The connection is mathematically and physically impossible, preventing a wrong-route error.) ● Distractor Analysis: ○ A is incorrect: It will not connect at all. ○ C is incorrect: Pumps cannot detect syringe thread types. ○ D is incorrect: It simply won't thread. The Mentor's Analysis: Before ENFit, exhausted clinicians routinely accidentally connected enteral feeds to central venous lines, injecting formula directly into the heart—a 100% fatal error. ENFit physical geometry (female-to-male vs male-to-female) makes this impossible. Professional Intuition: Human vigilance degrades after 12 hours. Engineering controls never sleep. Q45: A patient with NSCLC is being treated with Datopotamab deruxtecan (Dato-DXd) as a preferred second-line agent per 2026 NCCN guidelines. What specific class of medication is this, and how does it function? A) It is a PD-L1 checkpoint inhibitor that unmasks the tumor to the immune system. B) It is an Antibody-Drug Conjugate (ADC) that binds to tumor-specific antigens to deliver a targeted cytotoxic payload. C) It is a first-generation Tyrosine Kinase Inhibitor (TKI) that blocks oral angiogenesis. D) It is a systemic alkylating chemotherapy agent. ● The Answer: B (It is an Antibody-Drug Conjugate (ADC) that binds to tumor-specific antigens to deliver a targeted cytotoxic payload.) ● Distractor Analysis: ○ A is incorrect: Pembrolizumab/Nivolumab are checkpoint inhibitors. ○ C is incorrect: Erlotinib is a 1st-gen TKI. ○ D is incorrect: Cisplatin is an alkylating-like agent.
The Mentor's Analysis: ADCs are the "Trojan Horses" of modern oncology. The antibody component seeks out the exact cancer cell, binds to it, gets internalized, and then detonates the chemotherapy payload strictly inside the tumor, sparing healthy tissue. Professional Intuition: Targeted therapy minimizes collateral damage. ADCs changed the survival trajectory of advanced lung cancer. Q46: A 28-year-old female presents with acute appendicitis requiring surgery. She manages her Type 1 Diabetes with an AID system. She is NPO for surgery. According to the 2026 ADA guidelines, how should her basal insulin be managed perioperatively? A) Discontinue the AID system completely and rely on sliding scale. B) Maintain the AID system; the automated algorithm will suspend basal delivery if hypoglycemia is predicted during the NPO state. C) Administer a large dose of NPH insulin prior to surgery to cover the NPO period. D) Disconnect the pump and start a dextrose infusion without insulin. ● The Answer: B (Maintain the AID system; the automated algorithm will suspend basal delivery if hypoglycemia is predicted during the NPO state.) ● Distractor Analysis: ○ A is incorrect: Sliding scale is reactive and increases variability. ○ C is incorrect: NPH peaks unpredictably and is highly dangerous in an NPO surgical patient. ○ D is incorrect: T1D patients must always have basal insulin to prevent DKA, even when NPO. The Mentor's Analysis: The 2026 ADA explicitly supports keeping the AID system running perioperatively when feasible. The AI algorithm evaluates glucose every 5 minutes and shuts off insulin before the patient drops, which is far safer than a human trying to guess basal requirements during anesthesia. Professional Intuition: Trust the technology. The algorithm computes faster than you do. Q47: A provider enters an order for empiric clarithromycin triple therapy for a patient with new-onset dyspepsia and a positive H. pylori stool antigen. The patient lives in North America and has no antibiotic susceptibility testing on file. What is the PROPER clinical response? A) Administer the medication as ordered. B) Request to change the order to optimized Bismuth Quadruple Therapy (BQT) per 2026 ACG guidelines due to clarithromycin resistance. C) Add a probiotic to the order to prevent C. diff. D) Change the order to levofloxacin sequential therapy. ● The Answer: B (Request to change the order to optimized Bismuth Quadruple Therapy (BQT) per 2026 ACG guidelines due to clarithromycin resistance.) ● Distractor Analysis: ○ A is incorrect: Blindly administering clarithromycin violates 2026 guidelines. ○ C is incorrect: Probiotics do not fix the resistance issue. ○ D is incorrect: Levofloxacin also requires susceptibility testing. The Mentor's Analysis: Clarithromycin resistance is soaring. The 2026 guidelines state that unless you have paper proof the bacteria is susceptible, clarithromycin is off the table. Using it empiricly just breeds superbugs and fails the patient. Professional Intuition: Do not execute outdated orders. Advocate for the evidence-based BQT protocol. Q48: A patient on the med-surg floor suddenly develops hypotension (MAP 55) and tachycardia (HR 120). The nurse assesses the capillary refill time (CRT) as 6 seconds and notes mottled knees. The provider orders a stat lactate, which comes back at 1.8 mmol/L. How should the nurse interpret this synthesized data? A) The normal lactate proves the patient is not in shock; hold all interventions. B) The patient is in profound shock indicated by the delayed CRT and mottling; the lactate is a lagging indicator or the patient has impaired lactate production. Escalate immediately. C) The tachycardia is benign anxiety; administer a sedative. D) The
